{"transactions":[{"id":728184,"issuer":{"id":4451,"kind":"organization","name":"Pediatrix Medical Group, Inc.","symbol":"MD"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC & Corp Sec"}}],"security":"Performance Share Unit","published_at":"2026-06-24T21:30:03.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Share Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both a service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to 115%, 125% and 135% of $22.66 for at least 20 consecutive trading days before the third anniversary of the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Performance Share Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both a service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to 115%, 125% and 135% of $22.66 for at least 20 consecutive trading days before the third anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Performance Share Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both a service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to 115%, 125% and 135% of $22.66 for at least 20 consecutive trading days before the third anniversary of the grant date."}],"balance_after":51000,"derivative":{"underlying":"Common Stock","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001193125-26-281304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/893949/000119312526281304/ownership.xml","form_type":"4"}},{"id":728183,"issuer":{"id":4451,"kind":"organization","name":"Pediatrix Medical Group, Inc.","symbol":"MD"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC & Corp Sec"}}],"security":"Common Stock","published_at":"2026-06-24T21:30:03.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":20036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the \"Plan\"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan."}],"balance_after":20036,"source":{"system":"sec-edgar","filing":"0001193125-26-281304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/893949/000119312526281304/ownership.xml","form_type":"4"}},{"id":2453240,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-01-04T17:10:03.000Z","date":"2022-01-04","kind":"disposition_to_issuer","acquired":false,"shares":10605,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"These performance-vested restricted stock units of the Issuer that were previously reported in connection with an award granted on March 2, 2020  were disposed of in exchange for a number of time-vested restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These performance-vested restricted stock units of the Issuer that were previously reported in connection with an award granted on March 2, 2020  were disposed of in exchange for a number of time-vested restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"These performance-vested restricted stock units of the Issuer that were previously reported in connection with an award granted on March 2, 2020  were disposed of in exchange for a number of time-vested restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10605},"source":{"system":"sec-edgar","filing":"0001209191-22-000967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919122000967/doc4.xml","form_type":"4"}},{"id":2453239,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-01-04T17:10:03.000Z","date":"2022-01-04","kind":"disposition_to_issuer","acquired":false,"shares":11309,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These unvested restricted stock units previously granted by the Issuer on March 3, 2021, which provided for a one-third vesting of shares on each of March 3, 2022, 2023 and 2024, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These unvested restricted stock units previously granted by the Issuer on March 3, 2021, which provided for a one-third vesting of shares on each of March 3, 2022, 2023 and 2024, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These unvested restricted stock units previously granted by the Issuer on March 3, 2021, which provided for a one-third vesting of shares on each of March 3, 2022, 2023 and 2024, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11309},"source":{"system":"sec-edgar","filing":"0001209191-22-000967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919122000967/doc4.xml","form_type":"4"}},{"id":2453238,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-01-04T17:10:03.000Z","date":"2022-01-04","kind":"disposition_to_issuer","acquired":false,"shares":8473,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These unvested restricted stock units previously granted by the Issuer on March 2, 2020 , which provided for vesting in equal increments on each of March 2, 2022 and 2023, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These unvested restricted stock units previously granted by the Issuer on March 2, 2020 , which provided for vesting in equal increments on each of March 2, 2022 and 2023, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"These unvested restricted stock units previously granted by the Issuer on March 2, 2020 , which provided for vesting in equal increments on each of March 2, 2022 and 2023, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8473},"source":{"system":"sec-edgar","filing":"0001209191-22-000967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919122000967/doc4.xml","form_type":"4"}},{"id":2453237,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2022-01-04T17:10:03.000Z","date":"2022-01-04","kind":"disposition_to_issuer","acquired":false,"shares":2961,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the \"Merger Agreement\"), by and among the Issuer, Centene Corporation (\"Centene\") and Mayflower Merger Sub, Inc. (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the \"Common Stock\") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the \"Merger Agreement\"), by and among the Issuer, Centene Corporation (\"Centene\") and Mayflower Merger Sub, Inc. (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the \"Common Stock\") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-000967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919122000967/doc4.xml","form_type":"4"}},{"id":2810864,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Restricted Stock Units","published_at":"2021-03-04T18:34:42.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":11309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted Stock Units shall vest in one third increments on each of March 3 of 2022, 2023 and 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."}],"balance_after":11309,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11309},"source":{"system":"sec-edgar","filing":"0001209191-21-017982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919121017982/doc4.xml","form_type":"4"}},{"id":2810863,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Restricted Stock Units","published_at":"2021-03-04T18:34:42.000Z","date":"2021-03-02","kind":"exercise","acquired":false,"shares":4237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on March 2, 2020.  Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remainder of 8,473 Restricted Stock Units shall vest in equal increments on March 2, 2022 and 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."}],"balance_after":8473,"derivative":{"exercise_price":0,"exercise_date":"2021-03-02","underlying":"Common Stock","underlying_shares":4237},"source":{"system":"sec-edgar","filing":"0001209191-21-017982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919121017982/doc4.xml","form_type":"4"}},{"id":2810862,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2021-03-04T18:34:42.000Z","date":"2021-03-02","kind":"tax_withholding","acquired":false,"shares":1276,"price":93,"value":118668.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the portion of shares withheld by the Company in order to pay taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Closing price on NASDAQ on March 2, 2021."}],"balance_after":2961,"source":{"system":"sec-edgar","filing":"0001209191-21-017982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919121017982/doc4.xml","form_type":"4"}},{"id":2810861,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2021-03-04T18:34:42.000Z","date":"2021-03-02","kind":"exercise","acquired":true,"shares":4237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on March 2, 2020.  Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":4237,"source":{"system":"sec-edgar","filing":"0001209191-21-017982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919121017982/doc4.xml","form_type":"4"}},{"id":3230299,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Restricted Stock Units","published_at":"2020-03-04T13:55:39.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":12710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted Stock Units vest in one third increments on March 2nd of each of 2021, 2022 and 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Not applicable."}],"balance_after":12710,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12710},"source":{"system":"sec-edgar","filing":"0001209191-20-015943","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919120015943/doc4.xml","form_type":"4"}},{"id":3230298,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":35807,"kind":"person","name":"Haddock David","position":1,"cik":"0001501357","reported_name":"Haddock David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2020-03-04T13:55:39.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":10605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On the third anniversary of the grant date, Performance-Based Restricted Stock Units (\"PSUs\") vest based on achievement of total shareholder return (\"TSR\") performance relative to the S&P Health Services Industry Index over a three-year period beginning in 2020 and ending in 2022. Payout for vested PSUs ranges from 0% to 200% of the indicated number of shares, based on the Company's TSR percentile ranking compared to the TSR of the companies included in the selected market index. TSR is measured generally as the increase or decrease in the market value of the Company common stock with a deemed reinvestment of any dividends. If a participant terminates employment prior to the third anniversary of the grant date, the PSUs generally will be forfeited. PSUs have no voting rights and are generally non-transferable.  The indicated number of PSUs assumes 100% vesting, and the actual number of shares issued in settlement of the PSUs may be greater or less than the indicated number."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"(Continuation of Footnote 3) - Since the payout for PSUs can range from 0% to 200%, the maximum number of shares that could vest and be issued could be double the indicated number."}],"balance_after":10605,"derivative":{"exercise_price":0,"exercise_date":"2023-03-02","underlying":"Common Stock","underlying_shares":10605},"source":{"system":"sec-edgar","filing":"0001209191-20-015943","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919120015943/doc4.xml","form_type":"4"}}]}